Connect with us

HEALTH

Goldman Sachs Trims Price Target on LifeStance Health Group to $8 From $9, Maintains Neutral Rating

Published

on

[ad_1]


Newswires MT 2022

All news about LIFESTANCE HEALTH GROUP, INC.
11/15 Goldman Sachs cuts LifeStance health group price target to $8 from $9, maintains..

MT

11/14 Cowen cuts LifeStance Health Group price target to $8 from $10, maintains top performance.

MT

09/11 LIFESTANCE HEALTH GROUP, INC. Management report and analysis of the financial situation.

QA

09/11 UBS adjusts LifeStance health group price target to $6.50 from $7, maintains rate neutral.

MT

09/11 Insider Selling: Lifestance Health Group

MT

08/11 Lifestance Health: Overview of Third Quarter Results

QA

08/11 Lifestance Health: Q3 2022 Results Script

COULD

08/11 Transcript: LifeStance Health Group, Inc., Third Quarter 2022 Earnings Call, November 8, 20.

CI

08/11 Lifestance Health Group, Inc.: Results of operations and financial condition, regulatory…

QA

08/11 Earnings Flash (LFST) LIFESTANCE HEALTH posts Q3 loss of -$0.11, vs. Street East of -$0.01

MT

Analyst Recommendations on LIFESTANCE HEALTH GROUP, INC.

2022 sales 847M

2022 net income -212M

Net debt 2022 108M

PER 2022 ratio -9.83x
2022 return
Capitalization 2,211M
2,211M
EV / Sales 2022 2.74x
EV / Sales 2023 2.37x
# of employees 5,431
Floating 84.6%

Chart LIFESTANCE HEALTH GROUP, INC.


Duration :

Period :




LifeStance Health Group, Inc. Technical Analysis Chart |  MarketScreener

Trends Technical Analysis LIFESTANCE HEALTH GROUP, INC.

Short term Middle term Long term
Tendencies Bearish Bearish Neutral

Evolution of the income statement

Sale

To buy

Medium consensus SURPASS
Number of analysts seven
Last closing price $5.88
Average target price $7.92
Average Spread / Target 34.6%


[ad_2]

Trending